| Literature DB >> 25105845 |
Jiechao Ge1, Minhuan Lan1, Bingjiang Zhou2, Weimin Liu2, Liang Guo2, Hui Wang2, Qingyan Jia2, Guangle Niu2, Xing Huang2, Hangyue Zhou2, Xiangmin Meng2, Pengfei Wang2, Chun-Sing Lee3, Wenjun Zhang3, Xiaodong Han4.
Abstract
Clinical applications of current photodynamic therapy (PDT) agents are often limited by their lowEntities:
Mesh:
Substances:
Year: 2014 PMID: 25105845 PMCID: PMC4143951 DOI: 10.1038/ncomms5596
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919
Figure 1Characterization of GQDs.
(a) TEM images. Scale bar, 20 nm. (b) HRTEM images. Scale bar, 2 nm. (c) XPS survey spectrum. (d) Deconvolution of high-resolution C1s XPS spectra.
Figure 2Photophysical and photochemical properties of GQDs.
(a) Normalized UV–vis absorption and emission spectra (λex=500 nm) of the GQDs dispersed in water at room temperature. The inserts show a photograph and fluorescence image of the GQD solution under UV light (365 nm). (b) Fluorescence decay curve (black line) of GQDs recorded at 680 nm with an excitation of 488 nm. Red line: the instrument noise; blue line: fitting of the fluorescence decay curve. Fit=A+B1exp(−t/τ1)+B2exp(−t/τ2)+B3exp(−t/τ3; τ1=0.27 ns, τ2=1.10 ns, τ3=7.52 ns). (c) A comparison of the photostabilities of the GQDs, CdTe QDs and PpIX. All of the samples were continuously irradiated using a 500-W xenon lamp. A0 and A are the absorbance of the samples at 470 nm before and after irradiation, respectively. After 75 min of irradiation, no obvious decline was observed in the absorbance of the GQDs, while the absorbance of PpIX and the CdTe QDs decreased below 78% of their initial value. (d) The ESR signals of 1O2 (up) and other ROS (down) obtained upon irradiation of GQDs for 8 min in the presence of 2,2,6,6-Tetramethylpiperidine and 5-tert-butoxycarbonyl 5-methyl-1-pyrroline N-oxide, respectively. (e) The normalized absorbance of Na2-ADPA at 378 nm as a function of irradiation time in the presence of GQDs and RB. (f) The 1O2 emissions at ~1,280 nm induced by the GQDs and RB in a CH3CN-D2O mixture solution (v/v=15/1) under excitation with a 532-nm laser.
Figure 3In vitro imaging and PDT.
(a) Confocal fluorescent microscopy image of HeLa cells labelled with GQDs (0.4 μM). Scale bar, 20 μm. (b) Time-dependent confocal bright field and (c) corresponding fluorescence images of HeLa cells incubated with GQDs (0.4 μM) and Hoechst 33342 (1.8 μM) after irradiation with 405 and 633 nm lasers. Scale bar, 50 μm. Dose-dependent PDT effects of the cell viability of HeLa cells: (d) GQDs in the concentration range 0.036–1.8 μM and (e) PpIX in the concentration range 0.36–18 μM.
Figure 4In vivo imaging and PDT.
(a) Bright-field image and (b) red-fluorescence image after subcutaneous injection of GQDs in different areas. The excitation wavelength was 502–540 nm, and the collected fluorescence channel was 695–775 nm. (c) Photographs of mice after various treatments on the 1st, 9th, 17th and 25th day. (PDT: GQDs+light irradiation; C1: GQDs only; C2: light irradiation only.) (d) Time-dependent tumour growth curves (n=5) after different treatments. P<0.05 for each group.
Figure 5Multistate sensitization mechanism.
(a) Schematic illustration of the 1O2 generation mechanisms by conventional PDT agents (left) and GQDs (right). (b) Fluorescence intensity of GQDs at 680 nm versus the O2 concentration in solution. (c) The dependence of the 1O2 quantum yield (QΔ) on the fluorescence intensity ratio at 680 nm (F/F0).